Related references
Note: Only part of the references are listed.Extending the Treatment Options in Alcohol Dependence: A Randomized Controlled Study of As-Needed Nalmefene
Karl Mann et al.
BIOLOGICAL PSYCHIATRY (2013)
The glycine reuptake inhibitor Org24598 and acamprosate reduce ethanol intake in the rat; tolerance development to acamprosate but not to Org24598
Helga H. Lido et al.
ADDICTION BIOLOGY (2012)
Medications development to treat alcohol dependence: a vision for the next decade
Raye Z. Litten et al.
ADDICTION BIOLOGY (2012)
Small Conductance Calcium-Activated Potassium Type 2 Channels Regulate Alcohol-Associated Plasticity of Glutamatergic Synapses
Patrick J. Mulholland et al.
BIOLOGICAL PSYCHIATRY (2011)
Chlorzoxazone, an SK-Type Potassium Channel Activator Used in Humans, Reduces Excessive Alcohol Intake in Rats
F. Woodward Hopf et al.
BIOLOGICAL PSYCHIATRY (2011)
Pharmacologically induced alcohol craving in treatment seeking alcoholics correlates with alcoholism severity, but is insensitive to acamprosate
John C. Umhau et al.
NEUROPSYCHOPHARMACOLOGY (2011)
An integrated genome research network for studying the genetics of alcohol addiction
Rainer Spanagel et al.
ADDICTION BIOLOGY (2010)
Glycine Receptors in the Nucleus Accumbens Involved in the Ethanol Intake-Reducing Effect of Acamprosate
PeiPei Chau et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2010)
Glycine Receptors Involved in Acamprosate's Modulation of Accumbal Dopatnine Levels: An In Vivo Microdialysis Study
PeiPei Chau et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2010)
Effect of Acamprosate on Magnetic Resonance Spectroscopy Measures of Central Glutamate in Detoxified Alcohol-Dependent Individuals A Randomized Controlled Experimental Medicine Study
John C. Umhau et al.
ARCHIVES OF GENERAL PSYCHIATRY (2010)
Acamprosate: A Prototypic Neuromodulator in the Treatment of Alcohol Dependence
Barbara J. Mason et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2010)
Compulsive alcohol drinking in rodents
Valentina Vengeliene et al.
ADDICTION BIOLOGY (2009)
Alcohol and opioid dependence medications: Prescription trends, overall and by physician specialty
Tami L. Mark et al.
DRUG AND ALCOHOL DEPENDENCE (2009)
Alcohol and Global Health 1 Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders
Juergen Rehm et al.
LANCET (2009)
Alcoholism: A Systems Approach From Molecular Physiology to Addictive Behavior
Rainer Spanagel
PHYSIOLOGICAL REVIEWS (2009)
Acamprosate: Recent findings and future research directions
Karl Mann et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2008)
Effects of acamprosate on neuronal receptors and ion channels expressed in Xenopus oocytes
Matthew T. Reilly et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2008)
Drugs for relapse prevention of alcoholism: ten years of progress
Rainer Spanagel et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2008)
The pathogenesis of alzheimers disease - Is it a lifelong Calciumopathy?
Grace E. Stutzmann
NEUROSCIENTIST (2007)
Behavioural assessment of drug reinforcement and addictive features in rodents: an overview
Carles Sanchis-Segura et al.
ADDICTION BIOLOGY (2006)
The alcohol-preferring P rat and animal models of excessive alcohol drinking
Richard L. Bell et al.
ADDICTION BIOLOGY (2006)
The acute anti-craving effect of acamprosate in alcohol-preferring rats is associated with modulation of the mesolimbic dopamine system
MS Cowen et al.
ADDICTION BIOLOGY (2005)
The effects of acamprosate and neramexane on cue-induced reinstatement of ethanol-seeking behavior in rat
D Bachteler et al.
NEUROPSYCHOPHARMACOLOGY (2005)
Neuroprotective and abstinence-promoting effects of acamprosate - Elucidating the mechanism of action
P De Witte et al.
CNS DRUGS (2005)
The clock gene Per2 influences the glutamatergic system and modulates alcohol consumption
R Spanagel et al.
NATURE MEDICINE (2005)
The reinstatement model of drug relapse: history, methodology and major findings
Y Shaham et al.
PSYCHOPHARMACOLOGY (2003)
Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism - A double-blind, placebo-controlled study
F Kiefer et al.
ARCHIVES OF GENERAL PSYCHIATRY (2003)
The anti-craving compound acamprosate acts as a weak NMDA-receptor antagonist, but modulates NMDA-receptor subunit expression similar to memantine and MK-801
G Rammes et al.
NEUROPHARMACOLOGY (2001)